Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Commentary · 2 Dec 2022 Research article · 31 Oct 2022 Correlation of Serum Prostate Specific Antigen (PSA) with Incidentally Detected Prostatic Cancer in Patients Undergoing TURP for Clinically Benign Prostatomegaly: A Single Centre Study
Objective: The aim of this study is to estimate the incidence of prostatic cancer in patients undergoing transurethral resection of prostate for clinically benign prostatomegaly and its correlation with serum…
Research article · 13 Oct 2022 Role of Serum Prostatic Acid Phosphatase on Prostate Cancer Patients
well known that serum prostatic acid phosphatase (SPAP) may have a great role on Prostate Cancer Patients (PCPs), but its effects are not clearly identified in the prostate cancer literature
Conference proceeding · 30 Jul 2022 Isolation of prostate cancer-derived urinary EV subpopulation leads to the identification of novel prostate cancer biomarkers
valent anti- STEAP1, STEAP2, and PSMA dynabeads to overcome this obstacle by enriching Prostate Cancer (PC)-derived extracellular vesicles from urine samples of 16 patients with PC and Benign Prostatic
Conference abstract · 15 Jul 2022 Chakras Energies Deficiencies as a Factor of no Improvement of Prostate specific Antigen Exams in Patients Undergoing Prostate cancer Treatment
Introduction: Prostate cancer is the second most common cancer and the fifth leading cause of cancer-associated mortality among men worldwide.1 Screening for prostate cancer with serum prostate-specific antigen ... aims…
Perspective · 28 Feb 2022 Role of Prostate Specific Antigen as Biomarker in Diagnosing Prostate Cancer
Conference abstract · 15 Dec 2021 Chakras energies deficiencies as a factor of no improvement of prostate-specific antigen exams in patients undergoing prostate cancer treatment
Introduction: Prostate cancer is the second most common cancer and the fifth leading cause of cancer-associated mortality among men worldwide.1 Screening for prostate cancer with serum prostate-specific antigen ... aims…
Conference abstract · 9 Aug 2021 Relationship between Serum prostate specific antigen and prostate sonography in asymptomatic Ugandan adult males attending a tertiary hospital
Prostate cancer is the second leading cause of cancer deaths (after lung cancer) in men at about 20.1 per 100,000 men per year. Serum prostate-specific antigen (PSA) levels ... used to screen men at risk of prostate…
Article · Jul 2021 Evolution of Low-dose-rate Brachytherapy Imaging Equipment in the Prostate.
Communication Low dose rate brachytherapy has traditionally been used to treat cancers of the prostate, head and neck, breast, cervical, endometrium, oesophagus, bronchial lesions [1]. Permanent implants have gained…
Research article · 15 Feb 2021 Novel therapeutic anticancer property of Vernonia amygdalina Delile towards the treatment of prostate cancer
Prostate cancer is one of the common cancers in males and its incidence keeps increasing globally. Approximately 81% of prostate cancer is diagnosed during the early stage of the disease ... treatment options for…
Review article · 2021 Evaluation of the Anatomopathological Result of the Anatomical Pieces Resulting from a Prostatic Adenomectomy by High Approach in Patients Operated for Benign Hypertrophy of the Prostate at the Hospital of Tanguieta Zone
Objectives: To determine the correlation between digital rectal examinations, prostate volume, PSA level and pathological results after upper prostate adenomectomy indicated in the event of benign prostatic hypertrophy…
Short communication · 2021 The accuracy of out-of-field dose calculations of a commercial model based algorithm in sliding window inaccuracy for modern technique of patients with prostate cancer
Delta4+ phantom in 9 field sliding window IMRT technique for 10 patients with prostate cancer. The dose outside the field was calculated in absolute organ dose value and dose distribution
Short communication · 2021 Study of the frequency of occurrence of polymorphisms in patients with prostate cancer in the Kazakh population.
Statement of the Problem. The incidence of prostate cancer (PCa) due to increased life expectancy is steadily increasing. Currently, a list of polymorphisms associated with the risk of tumors, their ... study the…
Review article · 30 Nov 2020 Role of Mitochondrial Zinc in Progression of Prostate Cancer: A Diagnostic Biomarker for Prostate Cancer
Prostate gland is a complex organ found in men, having different components which are named as peripheral, central zone and a periurethral region. Biomarkers development for screening and detection ... prostate cancer…
Review article · 3 Nov 2020 Usefulness of Prostate Specific Antigen Density in Prostate Cancer Detection among Men with PSA of 4-10 ng/ml
Background: Prostate cancer (CaP) is a common malignancy in men and late presentation is still an issue. The discovery of PSA has revolutionized the diagnosis of CaP however has difficulties ... discriminating malignant…
Conference abstract · Aug 2020 MICRORNA’S SIGNATURE AND IT’S ROLE IN CARCINOGENESIS FOR BIOMAKER OF PROSTATE CANCER
usual diagnostic method to diagnostic Prostate cancer is the PSA (prostate specific antigen) method. However this method is considered to be less effective because the interpretation of the value ... cancer patients can…
Research article · 28 Jul 2020 Benign Prostatic Hyperplasia and Chronic Prostatitis Thermobalancing Therapy Can Prevent Sexual Dysfunction and Depression Linked to Medications: Importance During a Pandemic.
Introduction: Many men live with chronic prostate diseases, such as Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS). Medications widely prescribed ... groups without…
Article · 26 Jun 2020 Prostate cancer in Trinidad and Tobago: A response to andldquo;The epidemiology, histopathology and screening prospective of prostate cancer in Trinidadandrdquo
Prostate cancer is very common in Trinidad and Tobago but access to and uptake of screening remains limited. In this article, we respond to a recently published article on prostate ... cancer in Trinidad. We also…
Conference abstract · 4 May 2020 Targeting Prostate Cancer Cells with Hybrid Elastin-Like Polypeptide/Liposome Nanoparticles
long time, prostate cancer has been considered chemo-refractory. Only during the last 10-15 years, have good results been achieved in clinic trials with taxane derivatives such as docetaxel ... limit optimal dosage and…
Conference abstract · 13 Apr 2020 Prostatic urethral lift: a historic shift towards minimally invasive urology
Maximilian Stern introduced the first resectoscope and performed the first transurethral resection of the prostate (TURP) in 1926.1 The design was advanced in 1931 by Joseph McCarthy with the addition ... Ryall and…
Conference abstract · 24 Jan 2020 Targeting to prostate cancer cells by using ligand conjugated polymeric nanoparticles as drug carrier
overcome the lack of specificity of conventional chemotherapeutic agents for the treatment of prostate cancer, the second most common cancer in men. The aim of the current study ... nanoparticles will be conjugated with…
Conference abstract · 2020 Impact of hybrid imaging with Prostate-specific membrane antigen to target prostate cancer therapy

